Literature DB >> 24976699

Palliative care and end-stage colorectal cancer management: the surgeon meets the oncologist.

Renato Costi1, Francesco Leonardi1, Daniele Zanoni1, Vincenzo Violi1, Luigi Roncoroni1.   

Abstract

Colorectal cancer (CRC) is a common neoplasia in the Western countries, with considerable morbidity and mortality. Every fifth patient with CRC presents with metastatic disease, which is not curable with radical intent in roughly 80% of cases. Traditionally approached surgically, by resection of the primitive tumor or stoma, the management to incurable stage IV CRC patients has significantly changed over the last three decades and is nowadays multidisciplinary, with a pivotal role played by chemotherapy (CHT). This latter have allowed for a dramatic increase in survival, whereas the role of colonic and liver surgery is nowadays matter of debate. Although any generalization is difficult, two main situations are considered, asymptomatic (or minimally symptomatic) and severely symptomatic patients needing aggressive management, including emergency cases. In asymptomatic patients, new CHT regimens allow today long survival in selected patients, also exceeding two years. The role of colonic resection in this group has been challenged in recent years, as it is not clear whether the resection of primary CRC may imply a further increase in survival, thus justifying surgery-related morbidity/mortality in such a class of short-living patients. Secondary surgery of liver metastasis is gaining acceptance since, under new generation CHT regimens, an increasing amount of patients with distant metastasis initially considered non resectable become resectable, with a significant increase in long term survival. The management of CRC emergency patients still represents a major issue in Western countries, and is associated to high morbidity/mortality. Obstruction is traditionally approached surgically by colonic resection, stoma or internal by-pass, although nowadays CRC stenting is a feasible option. Nevertheless, CRC stent has peculiar contraindications and complications, and its long-term cost-effectiveness is questionable, especially in the light of recently increased survival. Perforation is associated with the highest mortality and remains mostly matter for surgeons, by abdominal lavage/drainage, colonic resection and/or stoma. Bleeding and other CRC-related symptoms (pain, tenesmus, etc.) may be managed by several mini-invasive approaches, including radiotherapy, laser therapy and other transanal procedures.

Entities:  

Keywords:  Chemotherapy; Colorectal cancer; Multimodal treatment; Palliative care; Radiotherapy; Stenting; Surgery

Mesh:

Substances:

Year:  2014        PMID: 24976699      PMCID: PMC4069290          DOI: 10.3748/wjg.v20.i24.7602

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  169 in total

1.  How aggressive should we be in patients with stage IV colorectal cancer?

Authors:  Li-Jen Kuo; Shuh-Yan Leu; Mei-Ching Liu; James Jer-Min Jian; Skye Hongiun Cheng; Chung-Ming Chen
Journal:  Dis Colon Rectum       Date:  2003-12       Impact factor: 4.585

2.  Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial.

Authors:  Ruben Veldkamp; Esther Kuhry; Wim C J Hop; J Jeekel; G Kazemier; H Jaap Bonjer; Eva Haglind; Lars Påhlman; Miguel A Cuesta; Simon Msika; Mario Morino; Antonio M Lacy
Journal:  Lancet Oncol       Date:  2005-07       Impact factor: 41.316

3.  Initial presentation with stage IV colorectal cancer: how aggressive should we be?

Authors:  S A Rosen; J F Buell; A Yoshida; S Kazsuba; R Hurst; F Michelassi; J M Millis; M C Posner
Journal:  Arch Surg       Date:  2000-05

4.  Bevacizumab in stage II-III colon cancer: 5-year update of the National Surgical Adjuvant Breast and Bowel Project C-08 trial.

Authors:  Carmen J Allegra; Greg Yothers; Michael J O'Connell; Saima Sharif; Nicholas J Petrelli; Samia H Lopa; Norman Wolmark
Journal:  J Clin Oncol       Date:  2012-12-10       Impact factor: 44.544

5.  Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement?

Authors:  René Adam; Robbert J de Haas; Dennis A Wicherts; Thomas A Aloia; Valérie Delvart; Daniel Azoulay; Henri Bismuth; Denis Castaing
Journal:  J Clin Oncol       Date:  2008-08-01       Impact factor: 44.544

6.  The clinical benefit of bevacizumab in metastatic colorectal cancer is independent of K-ras mutation status: analysis of a phase III study of bevacizumab with chemotherapy in previously untreated metastatic colorectal cancer.

Authors:  Herbert I Hurwitz; Jing Yi; William Ince; William F Novotny; Oliver Rosen
Journal:  Oncologist       Date:  2009-01-14

7.  Management of obstructive colorectal cancer with endoscopic stenting followed by single-stage surgery: open or laparoscopic resection?

Authors:  F Stipa; A Pigazzi; B Bascone; A Cimitan; G Villotti; A Burza; A Vitale
Journal:  Surg Endosc       Date:  2007-11-20       Impact factor: 4.584

8.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

9.  GKAs for diabetes therapy: why no clinically useful drug after two decades of trying?

Authors:  Franz M Matschinsky
Journal:  Trends Pharmacol Sci       Date:  2013-01-07       Impact factor: 14.819

10.  The role of primary tumour resection in patients with stage IV colorectal cancer.

Authors:  V R Konyalian; D K Rosing; J S Haukoos; M R Dixon; R Sinow; S Bhaheetharan; M J Stamos; R R Kumar
Journal:  Colorectal Dis       Date:  2007-06       Impact factor: 3.788

View more
  15 in total

1.  [Palliative surgery in visceral medicine. Exemplified by colorectal and gastric cancer].

Authors:  H Ptok; I Gastinger; S Wolff; C Bruns; H Lippert
Journal:  Chirurg       Date:  2016-03       Impact factor: 0.955

2.  A scoring model for predicting survival following primary tumour resection in stage IV colorectal cancer patients with unresectable metastasis.

Authors:  S R Dorajoo; W J H Tan; S X Koo; W S Tan; M H Chew; C L Tang; H L Wee; C W Yap
Journal:  Int J Colorectal Dis       Date:  2015-10-21       Impact factor: 2.571

Review 3.  A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.

Authors:  Yi Li; Ji Wang; Xiaowei Ma; Li Tan; Yanli Yan; Chaofan Xue; Beina Hui; Rui Liu; Hailin Ma; Juan Ren
Journal:  Int J Biol Sci       Date:  2016-07-17       Impact factor: 6.580

4.  Meta-analysis of outcomes of patients with stage IV colorectal cancer managed with chemotherapy/radiochemotherapy with and without primary tumor resection.

Authors:  Ko-Chao Lee; Yu-Che Ou; Wan-Hsiang Hu; Chia-Cheng Liu; Hong-Hwa Chen
Journal:  Onco Targets Ther       Date:  2016-11-15       Impact factor: 4.147

5.  Autologous tumor immunizing devascularization of an invasive colorectal cancer: A case report and literature review.

Authors:  Pavel Vašek; Josef Krajnik; David J Kopsky; Vladimir Kalina; Marek Frydrych
Journal:  Mol Clin Oncol       Date:  2016-09-21

6.  Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.

Authors:  Anand Mahadevan; Oliver Blanck; Rachelle Lanciano; Anuj Peddada; Srinath Sundararaman; David D'Ambrosio; Sanjeev Sharma; David Perry; James Kolker; Joanne Davis
Journal:  Radiat Oncol       Date:  2018-02-13       Impact factor: 3.481

7.  Krill oil extract suppresses the proliferation of colorectal cancer cells through activation of caspase 3/9.

Authors:  Abilasha Gayani Jayathilake; Elif Kadife; Rodney Brain Luwor; Kulmira Nurgali; Xiao Qun Su
Journal:  Nutr Metab (Lond)       Date:  2019-08-17       Impact factor: 4.169

8.  What Should We Recommend for Colorectal Cancer Screening in Adults Aged 75 and Older?

Authors:  Anuj Arora; Sami A Chadi; Tyler Chesney
Journal:  Curr Oncol       Date:  2021-07-09       Impact factor: 3.677

9.  Influence of the Twist gene on the invasion and metastasis of colon cancer.

Authors:  Duowei Wang; Bikash Rai; Feng Qi; Tong Liu; Jinmiao Wang; Xiaodong Wang; Bozhao Ma
Journal:  Oncol Rep       Date:  2017-11-06       Impact factor: 3.906

10.  Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases.

Authors:  Fotios Loupakis; Shruti Sharma; Madiha Derouazi; Sabina Murgioni; Paola Biason; Mario Domenico Rizzato; Cosimo Rasola; Derrick Renner; Svetlana Shchegrova; Allyson Koyen Malashevich; Meenakshi Malhotra; Himanshu Sethi; Bernhard G Zimmermann; Alexey Aleshin; Solomon Moshkevich; Paul R Billings; Jonathon D Sedgwick; Marta Schirripa; Giada Munari; Umberto Cillo; Pierluigi Pilati; Angelo Paolo Dei Tos; Vittorina Zagonel; Sara Lonardi; Matteo Fassan
Journal:  JCO Precis Oncol       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.